COMPANY PROFILE · /formation-bio
F
Formation Bio
Formation Bio uses AI to accelerate drug development timelines and de-risk clinical programs through predictive modeling and patient selection. The company raised $372M in a Series D round led by Andreessen Horowitz in 2024.
Fresh · 5d ago
Latest valuation
—
Annual Recurring Revenue
—
Headcount
—
Funding total
$600M+
OVERVIEW
Flagship deal in clinical trial AI; operates at intersection of drug discovery and payer workflows. Platform used by major pharma partners for trial design and patient stratification.
Status
active
Tier
master-list
Profitability
—
Pricing
enterprise
FUNDING HISTORY · 0
No funding rounds on file.
PRODUCTS · 0
No products catalogued yet. Press Refresh above to ask the research agent.
TEAM · 0 key people
No people linked.
SOURCES · 0 cited
No citations stored yet. Run the research agent to attach per-claim sources.